Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs >

22nd Century Group (XXII)

XXII RSS Feed
Add XXII Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator Tamtam, KarinCA, PinkieSwear, TOB, jockinmikeg, Grape Ape
Search This Board:
Last Post: 10/22/2014 10:53:04 PM - Followers: 219 - Board type: Free - Posts Today: 56

22nd Century Group Inc.

 

data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wCEAAkGBhQQEBUSERQWFRUVEh8UFhIYGRUYGhgWGBUfFyAYGBgZGyYfIBojHBgWIjsgIycpLCwuGB8yNjAqNiYrLCoBCQoKDgwOFA8PFSkdHCUvKiktLTU1NSoyNSwpKyk1KjM1KikrKSw1KSw2KSksMywpKSo1MzUsNCk1KSkpLSwsNf/AABEIAG0BzAMBIgACEQEDEQH/xAAcAAEAAgIDAQAAAAAAAAAAAAAABgcEBQEDCAL/xABIEAABAwIDBQMHBgoKAwAAAAABAAIDBBEFEiEGBzFBURMiYQgjQnGBkaEUMlJiscEVFzU2U3Jzk9HwGCSCkqKys7TC03TD0v/EABoBAQEBAQEBAQAAAAAAAAAAAAABAgYFBAP/xAApEQEAAgECBQMDBQAAAAAAAAAAAQIEAxEFIUFR8BKx4XGR0RUiIzEy/9oADAMBAAIRAxEAPwC8UREBERAREQEREBERAWJi+KMpYJJ5TZkbC93WwHAeJ4e1Zaiu9GkdLhFU1gJIjD7Dm1jw8/AE+xBQ21m3lViMjnSSObHfuwNcQxo8QPnHxPwWtwXaKoopBJTSvjIN7AnKfBzD3SPWFrkRp6k2D2tGJ0bZ7BrwckrBwDwBe3gQQR6/BSJVZuBo3tpJ5D8184DfHIyxI9pt7CrTRl1VVS2KN0jzZrGl7j0a0XJ9wXmnbTeNU4jK7vujgv3IGktGXkX2+c4+Og5L0DtrRvmw6qjj1e6meGgczkOnt4e1eU0WGbhWNz0jxJTyvjcDfuuIB/WbwI8CF6O3cbafhSk7RwDZo3ZJWjhe1w4eDhy5EELzIro8nykeI6qU3yOexg6FzQSfcHN96EreRERBERAREQEREBERAREQEREBERAREQEREBERAREQEREBERAREQEREBERAREQEREBERARaPauKsMOagka2RuvZua1wkHQE8HfA/FVHNvWxJji1z2tc02LTE0EEciLcVN3342BfJrvS0fTr7L4RUJ+NvEP0jP3bE/G3iH6Rn7tibvq/RsjvX7/AAvtFVOxW9xz5Oyry0Bx7k4AaGn6LwNLfW5c+otUG+oV3efkY2pj29N4coixsRxGOnidNM8MjYMznngB/Hw5o+ZkrhwuLFULj+/KrfO40mSOEaMD2BziB6TiToT0HBa78dWJ/pIv3TUXZLdrNxXaSOkoJGsDjcwSXDWn6jgDp4EadVrcE3BzueDVzMZGDq2K7nkdASAB69fUtJ+OrE/0kX7pqyMP3t4tUStihcx8jzlawRNuT7+HjyQX1hmGR00LIYWhkcbcrWjkPvJ435rKWmwyaWmpO0xGZhe1ueWQAMYwfRHUDrxJ9yqDaPfjUuqHfIsscI0bnYHOd9Y34X6Ii+FVO2m5EVErp6F7YnPOZ0LwcmY6ksI1bfpYj1cFCfx1Yn+ki/dNT8dWJ/pIv3TUVt8J3CVLnj5TNFGy+vZ5nuI8LgAes+5XPgmCxUcDIIG5WMFgOJJ4lzjzJOt1Q9JvfxWaRscTmPe92VrGwtJJPIBXhszBVNp2/LpGyTO1cGNDWs+qLcbdUG2RERBERAREQEREBERAREQEREBERAREQEREBERAREQEREBERAREQEREBERAREQEREBERAUK2/3dsr2mWGzKkDjwEgHov8ejvYdOE1RH66OtfRvF6TtLyvV0j4XujkaWPabOaRYgrqXoHbnYKPEWZm2ZO0dyTkfqv6t8eI+BofEsMkppXRTMLHtNi0/aOoPULEw7PCzaZVeXK3WPOjGVhbvN5ZpS2mqiTBwZJxMXgerPs9Wir1Efvr6FNek0vHJ6ircWihhNRJI1sTW5zJfTLyII435W43XnXeHvEkxSXK27KZh83Fzcfpv+t4cveVrK/EZpadtOZXGJji5sRPdBP8+y56laEi3FaiXG5eHfGttbnHSfOoiLJw3DZKmVsMLC+R5s1o5n7gOvJV8jjDsOkqJWwwsL5HmzWjiT/Dx5L0JsTsRBgtM6eocztcl5Zz81jeORnh8XH2Bc7FbFU+CUzp53N7XJeac8GN+gz6vxcfYFU+8bePJicnZx3ZTMd3I+BeR6b/HoOXrRHO8feO/E5OzjuymY7us4F5Hpv+5vL1qEoiKLuo6N80jY4ml73uytY0XJJ5BKKifNI2KJpe97srWDUkleiN2+7dmGR9pLZ9S9vefxEYPoM+93P1Ijjdtu2Zhsfay2fVPb3ncRGD6DPvdz9SnKIiCIiAiIgIiICIiAiIgIiICIiAiIgIiICIiAiIgIiICIiAiIgIiICIiAiIgIiICIiAiIgIiICju2WxUWJRWd3ZWjzcwGo8D1aenuUiWJiuKxUsLpp3hkbBdzj9g6k8LDijenqW07Rak7TDzXjWCS0czoZ25XD3OHJzTzBWCtrt3vBkxKoDgMkMdxFHpex4uefpGw04D3k6eKUOFwsTDscHPrkxtPK3b8PtdFRTB3r6rvRH3aulTVrNLxvDAw/CpaiZsELC+R5s1g/nQDjfgF6E2M2Mp8EpXTzvb2uS81QeDR9BnPLf2uPsCqjYzap2HVPahge1wySNsM2S9+67iD8Dz8PjePvClxKXILx07D3Iubj9N9tCeg4D3laiXHZuDfGt3r0nzq43i7xpMTkyMuymYe5Hzefpv8eg5evVQxEVfALvoaF88jYoml73uytYNSSUoKCSeRsUTS973ZWsHEn+efJeit3O7iPDI88ln1L29+TkwH0GeHU8/VYIjjdxu3ZhkfaSWfUvHffyYD6DPDqefqU2RabavayDDKY1FSSGg5WtaLue46hrRca2BOpA0RG5RVDH5Q0YyvkoahkDnWbNdpvboCA0kdA5TjGd4tHS0DK9zy6KUDsg0XdISL5Q02sRY3va1jdBJkVRReUNGCx01DURwvNmzXBvbmAWgG3QOVqYbiUdTCyaFwfHI0PY4cwfX9iDJREQEUV3jbdDB6VlQYe2zzCLLnyWuxz73yn6FreK2myuO/LqOGqydn2rM+S+bLqRa9hfh0QbZFots9sIcLpTUT3OuVkbbZnvOoaL+AJvyAPqVXf0gqlrWzvw0imc6zZMzwD4B5ZlJ0PuQXci1mze0EVfSx1UBJZILgHQgg2LXDqCCFs0BERARR/bbbGPCqYVMzHvaZBHlZlvdwJv3iBbRZmzG0DK+kiqo2ua2UEhrrZhZxbrYkckG0REQEREBERARVJj2/VwqnU2HUjqosJBeC45i3QljGNJLR9I8ei3G7re9HikrqaWEwVDWlwbfM14bxsSAQ4fRPjqgsNERAREQEREBERARFXu2O9oYdiMdF8mMnaBh7TtMtu0eW/NyHhbqgsJERAREQEREBERARFh4vi8VJC6ed4ZGwXLj9gHMnhZAxbFoqWF007wyNguXH7AOZPCw4rzht/t/Lik3NkDD5uH/m/q8/DgOZPG3230uKTa3ZAw+ahv8A439Xn4cBzJiqKL7ilLTcL4WXhOEy1UzIIGF8jzYNH2k8gOJJ4I3W00mLVnaWVDOHDT3LsV1YXu6ocNw6X5aWuLmXnqDpltwEXMWPC2pPuVKvnjc93ZFxYHHLmADi2+hIGl7dFmYdZgcRjIj0X5W9/OwuuaEOGvsK7EUeneldSs1tG8S1EsRabFd2H4fJUStihYXyPOVrBxJ/h48lnSxBwsVc+5jBaSOmM0ThJUnSZxFnR/UaOTPH0vZYaiXI5+BbGn1V519vq2u7rdzHhked9n1Lx35OTR9Bnh1PP3BTREVeUKHbxt3YxlkLHTuhETnO0YH5i4Aa3cOFj71MVFt5G2gwqhdOAHSOPZwtPAyOBNz9UAE+y3NBAd9NTT0WD0+GB4dK3sw1tgCGRNsZHAcMx99zxsUwPdQ7EsEoI5pnQGPtZQ3IHXE0mZtwXC3dsf7S0O7XZmCvmOJ4vVRPLpC5kMksYL3A/OkaTowHQMtY26WBtDeFvDjw7DzUQOZK+R3ZQZXNc3PbUnKeDQCbdbDmghW/Ovp6XDKbDWuDpWGMhotdscUZZnI5ZuA669FqMcxmtwjAcLbDK+F8naOeLC+Vzu0aCHA2sHBN1+y9PVSfhPFqqJ73vL2QySx3c4G3aSgu4XGjOGnSwW08ourZLS0T4nte0yyWc0hwNmtBsRpxQaXa7Fccp6SnxKWsyRz5AyGI2yZoy9uduWxJa0k8dVIdud6VRHgtDLE4R1FYy7pAB3RGLPLRyJcR6rldW9z82sP/AFqf/aPUM2/gP4GwV/o9hK2/iXtP2A+5B97f0OKw4bTur5xPDPI2VoJLnxSdk6zS4jmx7tASLt9937qfyNR/sB/mKr7fdi8UmC0AY9pMkjJWgEG7G07mk+wvaPWrB3U/kaj/AGA/zFBXflLVJ/qUfLzj/aMg/ip9UbGsrsDhoc3Zg00ID8ubKWNa6+W4uTY8+agnlK0RLKOa3dDpIyehcGuHvyu9yk+M7cin2cjq6eVrZTTxMjPdd52zWublNwS2z7jlZBgYmHbK4I9kUvbSvqLRPcwNDXSNF+7mNw0McfWQodV1GN0+Gx4w7EHlr3Nd2B1sx7rNcQRkIJt3bcHBYm1mN1eIbOxVVY7OfwkWtcGtZ5vsbDRoA+eJNVlxbE4ezBIK+qqqwxva1pijdGR2hcQWsY6w7pDtL6BpQbfb7eZVHCsOrKWUwPnziUMAILmANIGYHTMCfatPtfiuOU1JT4lLWZGT5Q2GI2yZoy9uduWxJa0k8dVi7xqaCPBMMFL2vYmSZ7O2DQ+znXNw3Tjf2KT74vzcw/8AaQf7SRBqN6VXWVuEUde+Zop5I4xJTAcai8l5BpwsOF124HPiFDs3JVtqrRlkYpmNAzQ/1rK+9227wJ68V97X/mfQ/rx/+xZNZIDsS2xBsGA25H5bwKDc4DtbVSbLzVj5nGoa2Qtms24yvsNLW0HgtBhG3tc/Zurq3VDzPHWMjZLZl2tJiuLZbek7lzX1s5WsbsbUAvaD5xlrj5zpBZvrNxoo9gX5o13/AJ7PthQb7YXFMcxU00olIpYaholkzNYZQJA59wBd1mnLa1vbdbPdttjW/huow+tndKGiRjA4NHejeCCMoHFlypFuI/IsX7ST/UKgO9NxwnaCKvYO7LHnNvpZDA8Dxylp/tIN/u32urcRxuqDp3GkiMjmxWblsZMkbb2vwuePoqz9pKoxUVTIOLKaR49bYyfuVb+TphGShnqXDvTz5QerYx/9Of7lZW0FIZqSoiHGSnewet0Zb96ClfJ3dHC2vqpiGiNjA6Q+izvOcb9NB7gpTg1DgsmLitpqzNVSSuc2Jr25HOewg93JfW5PHioZuCkhlNdQ1FrVETfNklpc1uZrwCCDezhw149FrsEpaaLauOOit2DKnKyzi4aREOs4kkjNm1ug2OIbe4s7Gaqio5XSF00sMMZDLMAce8CR6LQdSbDjqthtdtniWD4dT0s0t62Z8j3z5hIWxB1mhpItck8eQaeumFsZ+eFR+3qPscufKOhLa2kkI7pgLR62ykn4Oag42kxDGcBdTVE1aahsvzonEuaHNAJjdm8D85tuBWz3qbw6qGpoTRzuiiqKVkxaA03zvPG4Po2C7fKMrmOpaMNcDnldI23NmQd4eHeCh29CExHCGv0LMMhDr8i06+5BP9/G19XQGk+STOi7QS58oac2Xs7cQeGY+9ajert9XUU9EKedzQ+jZK9lmkPeXa30vrw0sunykqtj30LWuaSGSuIBB7rjHlOnI2NjzstTvnlDarDnHg2hiJ9QfdBlbV45jeC1FPUVVUJRNd5iBvH3SC6IsygDRw1b7Dor9oasSxMlbwewPHqcLj7VSvlHYlHJFQtY5ri7PKLEHuFrAHacjyPOx6KfUm29Jh8NFSVUpZM+liysySOvdoYNWtIHeBGqCZrzzvk/OKm/Vg/1XL0MvPO+T84qb9WD/Vcg2+8LbbEYMebSUc1mu7JrIXBuQvkFu8bXtc348lqMW2jxfBsVgjqqwziQskcwG8bo3vLC3KWjKRZ3ADku/bn876f9tT/cvnf1+WqP9hH/ALh6De7yduK2XFY8Iw6XsXEta+UaEve3P86xIa1hB014rEwTabEsJxmKgrp3VUUzmNzkE27U5Wva4i4s7Qg6Wv4LXVnmdtQZNA6obYn69OA23tNlYeO70GU2LRYaKcyPkdG0yB4GQyutq3KT3QQ7ignqKPUe3tHNWuoWSk1DC4OjySCxYLu7xbl09akKAiLBxnGYqOF087wxjBcnqeQA5uPRBzjGMRUkLp53hjGC5J+AA5k9F5v2929lxSa5uyBh81Dfh9Z3V5+HAePG3m3kuKTXddkLD5qG/D6zurz8OA8YuiiIszB8Hlq5mwQML5HmwA6cyTyaOZRTCMIlq5mQQML5HmwaPiSeTRzJXoXZXZSmwGkfNM9ufLeaoP8AkZzy34Di4psvstS4DRulme3PlvNUHn9Rg45b6ADUlU3vA3gy4pLbVlOw+bi/5v6uPuHAcySOd4O8KTFJbC7Kdh83F1+u/q77OHUmJNcQbhcIjUTMTvDZU9SHevou9YGFYbLUzMhgaXyPNmtH2+AHG54Kd7V7tqjD4mSuIlZlHaPaCMj+hH0b8He+2izMOp4fxKNXbT1Z/d0nv8oms7BMblo5mzQOyuHucObXDmCsFFl7NqxaJiY3h6L2N20ixKK7e7K0echJ1HiOrT196kS8uYZiclNK2aF5Y9puHD7COYPQ8VfGw+3seIx5TZk7R34uv1mdW+HEfFbiXJcQ4bOhM6mnzr7fCVqMbb7v4MXZGyofK0ROLm9m5rblwA1zMd0+JUnRV46q/wCjnh36Wq/vxf8AUtnV7k6OSkhpHSVAjge97SHR5iZSCcx7O2lhawCsFEFV/wBHPDv0tV/fi/6ltq7cxRzUUFEZKgR073vY4OjzEym5zEx2t0sAp8iCLbR7vIK6hhoZXytjgLC1zCwPPZxmMZiWkcHHgBquqv3ZUs+Gx4dIZDHCPNy3b2jXC/evly8yLWtZS5EFVU3k7UIjc18s7nFwIkBjaWgX7oGUjW+pNzoLW1vYmz+CMoqaKmiLnMiZkaXWLiL31sAL69FsUQa3aHZ2Cvp3U9SzPG7XoQRwc08nDr/FVtH5ONGJLmoqCy98nmwfUXBv3K20QaWo2OpX0PyAxD5PkDBGLi1jcEHjmvrfjdQKLydqMPGaoqXRB2YREsH+IN59QAVa6IIjtZuypcRggp3mSKOnBEbYiwWBaG2OZrtAAF3bS7vYK+ihopXytjhLC1zCwOPZxujFyWkcHHgBqpQiCL1e7umlwxmGvMhhYAGvu0SAtJIdcNtfU8rarUYDuYo6SGphzzSsqoxG8PLNA05gWlrBZwNjc34BT9EFVUHk70LC8ySzyZmlrQSxuS4tm0bq4cr6eC3lJuipY8Olw5sk/ZTTCZzi6POHNy6A5LW7g5dVOUQabZLZaLDKVtLC57mNc5wLy0uu43Ny0AfBUpvx2ugxCaKjp45HT08743EtGpNm5GWJLruA9wXoRYrMKha8yNijDybl4Y0OJPPNa90Gs2GwH5Dh1PTH50cQz/tHd93+JzlvURBWW0W4Siqp3TsklgL3ZnsZkLLk3JaHC7b9L28Fn4NuXoqSpp6mF0wfTjQZmEPdr3n9y9+9yIGg0U+RBDsM3X01PiT8SZJMZnue4sJZkvLe9gGA8+q2W2WxNPisAhqQe6czJGkB7HWtcEgix5ggg6dAt+iCr8I3AUcUzJJpZqgRkZYnloZobgOsLlvgCApDt5uzp8XbH2rnxyRAhkjMt8p9FwIsRz5W9pUvRBVw8nnD+yawyT5gSXSh0Yc64taxYQGjw66kqGb9KNrcSoYuLW0zGa82iUt1t4L0IsWqwuGVwdJFG9w4OcxriNb6Ejqgrmj8n2gjqRMXzOja/MKdxbl0N8rnWzFvhx6krX72MFZU4vhzIRI6pLmFzQPNsp2SFxedON83O1m8OCuBcZBe9tbWvzsg5UM2m3V02IVrK2WSZskYYA1hYG+bcXC4LCeJ6qZogh+K7sKapxJmIvkmErHMcGNLMl4+FwWE8uq42u3X02J1UdVNJM18TAxoYWBpDXl4uHMJvdx5qYoghu3O62lxZzZJS+OZgyiWMi5be4DgQQQCT0PisXY7c9S4dP8AKc8s84vlfIRZpIsXAAfOsSLklTxEERw7dlTQYk/EmPmMz3PcWlzMl5BY2AZfn1UuREGDjWNRUcDp53hjGDU8yeTWjm49F5u2727lxSbM67IWHzUN9APpO6vPXlwC+t4G2k2I1Lu07scT3MjhBuG2JbmPVxtx9iiyKIi4RWdg2DS1kzYIGF8jzoOQHNzjyaOZXoXZnZmlwCjfLK9ufLeaoPM8mMHHLfQNGpPisjd3sXDh9K0s70srGvkmIsTcXDR0aL8PaqW3mbZzV1W+N/digkcxkQOl2ktL3dXH4DQc7kdW3+8CXFJubIGHzcPwzv6vPw4DmTE0RFFlYVhUtVMyGBhfI82a0faTyA4kngsVekt2OxcNDSMlb35p42vfKRrZwDgxvRov7TqeViO/d/u+iwuHk+oePOS/HIzowfHieQErliDmlrgC0ixaRcEHQgjovpERSm8PdoaXNU0oLoOL4+Ji8R1Z9nq1Ver1YRfQqkt6WxsVJKyWDutmLrxW0a5trluugN+HL4LMw6jhvEZ1JjR1f76T+UAXbSVj4XtkicWPabtcNCCufk/j8E+T+PwWXuTMTyleewO8Rle0RS2ZUgat4CQD0mePVvu04TReW4WuY4OY4tc03DhcEEcwb8VfG7jaaSupSZgM8bsheNM+l8xHI/zotxLleJYEaP8ALp/57dvhLERFXiiIiAiIgIiICIiAiIgIiICIiAiIgIiICIiAiIgIiICIiAiIgIiICIiAiIgIiICIiD//2Q==


Ticker: XXII
(NYSE MKT)

Share Structure from latest 10-K:
O/S - 59,601,688 as of 8/11/14
Float - 39,500,000 as of 1/31/14

                                                                                                                                                                                                                                                                                                                        
                                                                                                                          
 
22nd Century is a plant biotechnology company whose proprietary technology through genetic engineering and plant breeding allows (i) the level of nicotine (and other nicotinic alkaloids) in the tobacco plant to be decreased or increased and (ii) the levels of cannabinoids to be decreased or increased, in addition to the cannabinoid profile being tailored. 22nd Century owns or is the exclusive licensee of 129 issued patents in 78 countries plus an additional 51 pending patent applications, and 22nd Century has co-exclusive rights to another 16 patent applications. Goodrich Tobacco is focused on commercial tobacco products and potential less harmful cigarettes. Botanical Genetics is focused on novel, cannabis plant varieties and cannabis-based products for human health, well-being and nutrition, in addition to industrial products refined from cannabis. Hercules Pharmaceuticals is focused on X-22, a prescription smoking cessation aid in development.

Editorial Opinion: "Patented and BAT-licensed altered nicotine technology that will disrupt a $700B Worldwide Tobacco Industry with 5 different revenue streams on both the consumer product and pharmaceutical side of smoking cessation, cannabis, and modified risk tobacco products - $1B+ mkt cap potential"
 

www.xxiicentury.com

XXII PIPELINE                               XXII TECHNOLOGY                            XXII PRODUCTS



 

Research and Recent News:



Chardan Capital Markets Analyst Reports 1/10/14    1/31/14    2/10/14   3/17/14    4/2/14    4/21/14    7/15/14


XXII RESEARCH REPORT - HTFBSN "Light This Fuse"


HTFBSN 22nd Century Group CEO Interview - November 2013
 

22nd Century Group to Acquire Participating Member of the Tobacco Master Settlement Agreement (MSA) - Sept 18, 2013
 

British American Tobacco Licenses 22nd Century Group Technology - Oct 1, 2013

22nd Century Group Warrant Exchange Eliminates 93% of Warrant Liability - Dec 16, 2013


22nd Century Group Files Annual Report and Provides Business Update - Jan. 30, 2014


22nd Century Group Approved to List Common Stock in NYSE MKT - Mar. 6, 2014


22nd Century Subsidiary Goodrich Tobacco Company Granted Federal Permit to Manufacture Tobacco Products - Mar. 10, 2014


22nd Century Group Files $45M Shelf Registration and Provides Business Update - Apr. 21, 2014


22nd Century Group Signs Letter of Intent w/ European Factory for Production of Nicotine-Free Cigarettes in Europe - May 29, 2014


22nd Century Group Added to Russell 3000, 2000, Global, and Microcap Indexes - Jun. 30, 2014


22nd Century Group Engages CRO for FDA Regulatory Activities for Company's Modified Risk Cigarettes - Jul. 11, 2014


22nd Century Group Partner NASCO Enters Agreement with Smoker Friendly International - Aug. 29, 2014


22nd Century Group Becomes Member of Tobacco Master Settlement Agreement (MSA) - Sep. 2, 2014


22nd Century Enters Cannabis Space - Sep. 18, 2014


22nd Century Granted Meeting w/FDA to Advance Development of a Potential Modified Risk Cigarette - Sep. 25, 2014


XXII Current Stock Chart:


 To learn more about 22nd Century Brands
Visit the links and images below:
         
                      GOLD MAGIC CIGARETTES                                                                                                    RED SUN CIGARETTES





 

                                                                    Home Dutch-

 
 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
XXII
Current Price
Volume:
Bid Ask Day's Range
Wiki
PostSubject
#15054  Sticky Note XXII responds to SA article vangorilla 08/27/14 03:24:26 PM
#13282  Sticky Note 22nd Century Group Added to Russell 3000, Russell TOB 07/01/14 12:20:30 PM
#4398  Sticky Note $XXII: BUY Recommendation $9 Target - Chardan Capital Report jockinmikeg 01/11/14 12:02:04 AM
#18443   Don't recall exact figures from the filings, but jockinmikeg 10/22/14 10:53:04 PM
#18442   We already see "to the moon" on the Lnp30 10/22/14 10:14:16 PM
#18441   Did I read correctly that if BAT takes Lnp30 10/22/14 10:11:22 PM
#18440   Thanks for the info, I am oblivious to petemantx 10/22/14 09:40:01 PM
#18439   It is not the fundamental connection with Page jockinmikeg 10/22/14 09:11:16 PM
#18438   You really think that many MJ investors are petemantx 10/22/14 09:07:19 PM
#18437   I agree that long-term share price appreciation that jockinmikeg 10/22/14 09:00:19 PM
#18436   Yep, many are starting to move but XXII 2014shelby 10/22/14 08:47:21 PM
#18435   Thanks, I knew there had to be some petemantx 10/22/14 08:24:32 PM
#18434   Yes, MJ stocks going through the roof again...many ARBITRARY & CAPRICIOUS 10/22/14 07:38:16 PM
#18433   Aww no it's not why you gotta fib Lnp30 10/22/14 07:15:28 PM
#18432   On another note, MJ basket stocks have historically jockinmikeg 10/22/14 06:40:19 PM
#18431   That is hilarious, because it is so appropriate. MrKerfluffle 10/22/14 06:34:30 PM
#18428   Dinner update is out ARBITRARY & CAPRICIOUS 10/22/14 05:51:01 PM
#18427   The portion of XXII shares owned by Russell jockinmikeg 10/22/14 05:42:42 PM
#18426   Quote Tamtam 10/22/14 05:38:55 PM
#18424   Serious question - What is the advantage of petemantx 10/22/14 04:45:14 PM
#18423   Watched a very interesting piece on CNBC last in4thelonghaul 10/22/14 04:31:30 PM
#18422   I agree. It's the same story day in Grape Ape 10/22/14 04:23:00 PM
#18421   We are all beating a dead horse. Lnp30 10/22/14 03:45:38 PM
#18420   Of course I believe in the share price Grape Ape 10/22/14 03:28:23 PM
#18419   Nicely said lol nymostwanted 10/22/14 03:23:20 PM
#18418   If you believe in the share price reaction jockinmikeg 10/22/14 03:19:17 PM
#18417   News on revenue will bring investors on.. nymostwanted 10/22/14 03:03:22 PM
#18416   I disagree. Good news makes this thing drop Grape Ape 10/22/14 03:02:29 PM
#18415   waiting for $2.80 confirmation, I don't mind buying nymostwanted 10/22/14 02:56:31 PM
#18414   I don't see why not. They simply Lnp30 10/22/14 12:45:10 PM
#18413   I agree it's a little befuddling and frustrating TheDane 10/22/14 12:34:05 PM
#18412   The question is rather if such statements shouldn't KraFtaVerK 10/22/14 12:20:57 PM
#18411   I see weak volume and similar L2 activity strut1702 10/22/14 12:18:16 PM
#18410   This is my opinion...management needs to get the strut1702 10/22/14 12:15:34 PM
#18409   (Okay...I'll keep it quiet.) TheDane 10/22/14 12:03:32 PM
#18408   Ssshhh... Don't jinx it pleaseee! ztockings 10/22/14 11:59:12 AM
#18407   I see that. Looks interesting. Maybe we can TheDane 10/22/14 11:43:07 AM
#18406   Did news come out somehwere? Bids are raising!!! nymostwanted 10/22/14 11:40:52 AM
#18405   "Although speculative , if they do deliver at streamingeagle88 10/22/14 11:10:24 AM
#18404   Anyone find the size of the trades a comatose 10/22/14 11:02:50 AM
#18403   This sux right now-start shipping product already!!! tombrady12nh 10/22/14 09:51:06 AM
#18402   I feel your frustration. All of the events gary122 10/22/14 09:47:06 AM
#18401   Maybe they are waiting until it's no longer TheDane 10/22/14 09:36:32 AM
#18400   Not quite the end of the month yet... ztockings 10/22/14 09:33:53 AM
#18397   I still think it's rather strange they mentioned KraFtaVerK 10/22/14 09:13:47 AM
#18394   I am blowing off my dissappointment that is all.... selinpinar 10/22/14 08:21:26 AM
#18393   I just don't see x22 going anywhere. Lnp30 10/22/14 07:04:04 AM
#18392   Thanks for the explanation but Maybe you weren't Lnp30 10/22/14 07:01:11 AM
#18391   that all may be true, but play institutional brooklyn13 10/22/14 05:57:06 AM
#18389   Fundamentals: stronger than ever. Company has enough cash jockinmikeg 10/22/14 03:42:47 AM
#18388   i can answer the "hostile takeover" question. streamingeagle88 10/22/14 12:26:47 AM
#18387   Until solid fundamental news hits the wires, the etradeedge 10/21/14 11:22:40 PM
#18386   mike or etrade. can i ask what you peterbelt100 10/21/14 11:21:42 PM
PostSubject